Harbin Pharmaceutical Group Co (SHSE:600664) Total Long-Term Liabilities : ¥414 Mil (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Harbin Pharmaceutical Group Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥414 Mil.

Harbin Pharmaceutical Group Co Total Long-Term Liabilities Historical Data

The historical data trend for Harbin Pharmaceutical Group Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Pharmaceutical Group Co Total Long-Term Liabilities Chart

Harbin Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

586.63

567.18

486.47

446.33

421.48

Harbin Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Liabilities	Get a 7-Day Free Trial															439.01	447.65	432.88	421.48	414.01

Harbin Pharmaceutical Group Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Harbin Pharmaceutical Group Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » Total Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018

Website

http://www.hayao.com

Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.

Executives

Liu Bo	senior management
Xia Ji Cheng	senior management
Qiu Fang Ju	Supervisors
Li Bang Dong	senior management
Jiang Hai Tao	senior management
Meng Xiao Dong	senior management
Lin Guo Ren	senior management
Wang Hai Sheng	senior management
Xu Hai Ying	Directors, senior managers
Liang Chen	senior management
Wang Peng Hao	senior management
Xiao Qiang	senior management
Bian Ke	Supervisors
Zhou Xing	senior management
Wei Shuang Ying	senior management

Harbin Pharmaceutical Group Co Headlines

No Headlines